References
- Craves F B, Law P Y, Hunt C A, Loh P Y. The metabolic disposition of radiolabeled enkephalins in vitro in situ. J. Pharmacol. Exp. Ther 1978; 206: 492–506
- Malfroy B, Swerts J P, Guyon A, Roques B P, Schwartz J-C. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978; 276: 523–526
- Knight M, Klee W A. The relationship between enkephalin degradation and opiate receptor occupancy. J. Biol. Chem 1978; 253: 3843–3847
- Sullivan S, Akil H, Barchas J D. Enkephalinase: Preliminary characterization and comparison with angiotensin-converting enzyme. Commun. Psychopharmacol 1978; 2: 525–531
- Benuck M, Marks N. Co-identity of brain angiotensin-converting enzyme with a membrane bound dipeptidyl carboxypeptidase inactivating Met-enkephalin. Biochem. Biophys. Res. Commun 1979; 88: 215–221
- Gorenstein C, Snyder S H. Two distinct enkephalinases: Solubilization, partial purification and separation from angiotensin-converting enzyme. Life Sci 1979; 25: 2065–2070
- Palenker J, Lentzen H, Brandt U. Enkephalin degradation by enkephalinergic neuroblastoma cells Involvement of angiotensin-converting enzyme. Naunyn-Schmiedeberg's Arch. Pharmacol 1984; 325: 214–217
- Lentzen H, Monden I, Linke J, Palenker J. No evidence for enkephalinase A on neuronal cells. Life Sci 1983; 33(Suppl. I)105–108
- Lentzen H, Palenker J. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells. FEBS Lett 1983; 153: 93–97
- Warren L, Glick M C, Nass M K. Membranes of animal cells. I. Methods of isolation of the surface membrane. J. Cell Physiol 1966; 68: 269
- Brunette D M, Till J E. A rapid method for the isolation of L-cell surface membranes using an aqueous two-phase polymer system. J. Membrane Biol 1971; 5: 215–224
- Altstein M, Vogel Z. On the inactivation of enkephalin by enkephalinase. Neurotransmitters and their receptors, U Z Littauer, et al. John Wiley & Sons, New York 1980; 497–507
- Ondetti M A, Rubin B, Cushman D W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 1977; 196: 441–444
- Cushman D W, Ondetti M A. Inhibitors of angiotensin-converting enzyme for treatment of hypertension. Biochem. Pharmacol 1980; 29: 1871–1877
- Stine M, Yang H, Costa Y TE. Inhibition of in situ metabolism of (3H) (Met5)-enkephalin analgesia by captopril. Brain Res 1980; 188: 295–299
- Roques B P, Fournie-Zaluski M C, Soroca E, Lecomte J M, Malfroy B, Llorens C, Schwartz J-C. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 1980; 288: 286–288